The ToxBank Data Warehouse: Supporting the Replacement of In Vivo Repeated Dose Systemic Toxicity Testing

The aim of the SEURAT‐1 (Safety Evaluation Ultimately Replacing Animal Testing‐1) research cluster, comprised of seven EU FP7 Health projects co‐financed by Cosmetics Europe, is to generate a proof‐of‐concept to show how the latest technologies, systems toxicology and toxicogenomics can be combined to deliver a test replacement for repeated dose systemic toxicity testing on animals. The SEURAT‐1 strategy is to adopt a mode‐of‐action framework to describe repeated dose toxicity, combining in vitro and in silico methods to derive predictions of in vivo toxicity responses. ToxBank is the cross‐cluster infrastructure project whose activities include the development of a data warehouse to provide a web‐accessible shared repository of research data and protocols, a physical compounds repository, reference or “gold compounds” for use across the cluster (available via wiki.toxbank.net), and a reference resource for biomaterials. Core technologies used in the data warehouse include the ISA‐Tab universal data exchange format, REpresentational State Transfer (REST) web services, the W3C Resource Description Framework (RDF) and the OpenTox standards. We describe the design of the data warehouse based on cluster requirements, the implementation based on open standards, and finally the underlying concepts and initial results of a data analysis utilizing public data related to the gold compounds.

[1]  L. James,et al.  Mechanisms of acetaminophen-induced liver necrosis. , 2010, Handbook of experimental pharmacology.

[2]  Bing Zhang,et al.  WebGestalt: an integrated system for exploring gene sets in various biological contexts , 2005, Nucleic Acids Res..

[3]  Matthew S Goldberg,et al.  Alternative Mitochondrial Electron Transfer as a Novel Strategy for Neuroprotection* , 2011, The Journal of Biological Chemistry.

[4]  Peter Sartipy,et al.  Concise Review: Human Pluripotent Stem Cell‐Based Models for Cardiac and Hepatic Toxicity Assessment , 2011, Stem cells.

[5]  David Attwell,et al.  A Preferential Role for Glycolysis in Preventing the Anoxic Depolarization of Rat Hippocampal Area CA1 Pyramidal Cells , 2005, The Journal of Neuroscience.

[6]  Jürgen Borlak,et al.  Drug‐induced phospholipidosis , 2006, FEBS letters.

[7]  Arnaud Tonnelier,et al.  Screening of chemicals for human bioaccumulative potential with a physiologically based toxicokinetic model , 2011, Archives of Toxicology.

[8]  Alan R. Boobis,et al.  IPCS Framework for Analyzing the Relevance of a Cancer Mode of Action for Humans , 2006 .

[9]  S. H. Yang,et al.  Experimental model of hepatic fibrosis following repeated periportal necrosis induced by allylalcohol. , 2000, Scandinavian journal of gastroenterology.

[10]  Olga Tcheremenskaia,et al.  Environment and Health , 2004, Frontiers Research Topics.

[11]  Smita Jagtap,et al.  Development of a neural teratogenicity test based on human embryonic stem cells: response to retinoic acid exposure. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[12]  Michael S Lajiness,et al.  Systems chemical biology and the Semantic Web: what they mean for the future of drug discovery research. , 2012, Drug discovery today.

[13]  Tara B. Manion,et al.  Discovery of microsomal triglyceride transfer protein (MTP) inhibitors with potential for decreased active metabolite load compared to dirlotapide. , 2011, Bioorganic & medicinal chemistry letters.

[14]  Michael Balls,et al.  Guidance on Good Cell Culture Practice , 2005, Alternatives to laboratory animals : ATLA.

[15]  Robert J Kavlock,et al.  Impact of environmental chemicals on key transcription regulators and correlation to toxicity end points within EPA's ToxCast program. , 2010, Chemical research in toxicology.

[16]  Howard T. Jacobs,et al.  Production of Mitochondrial Reactive Oxygen Species Protein in Hypoxia Occurs Independently α Stabilization of Hypoxia-inducible Factor-1 Cell Biology : , 2010 .

[17]  J. Williamson.  Glycolytic control mechanisms. 3. Effects of iodoacetamide and fluoroacetate on glucose metabolism in the perfused rat heart. , 1967, The Journal of biological chemistry.

[18]  L. del Peso,et al.  Accumulation of hypoxia-inducible factor-1alpha through a novel electrophilic, thiol antioxidant-sensitive mechanism. , 2007, Cellular signalling.

[19]  Karen Holtzblatt,et al.  Rapid Contextual Design: A How-To Guide to Key Techniques for User-Centered Design , 2004, UBIQ.

[20]  Melvin E Andersen,et al.  A mechanistic redefinition of adverse effects - a key step in the toxicity testing paradigm shift. , 2010, ALTEX.

[21]  A. Layton,et al.  Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy. , 2008, Rheumatology.

[22]  Garry R. Buettner,et al.  Thermodynamic and kinetic considerations for the reaction of semiquinone radicals to form superoxide and hydrogen peroxide. , 2010, Free radical biology & medicine.

[23]  Thomas C. Wiegers,et al.  The Comparative Toxicogenomics Database: update 2011 , 2010, Nucleic Acids Res..

[24]  Nina Jeliazkova,et al.  AMBIT RESTful web services: an implementation of the OpenTox application programming interface , 2011, J. Cheminformatics.

[25]  Nigel W. Hardy,et al.  Promoting coherent minimum reporting guidelines for biological and biomedical investigations: the MIBBI project , 2008, Nature Biotechnology.

[26]  Michael Erb,et al.  NQO1-Dependent Redox Cycling of Idebenone: Effects on Cellular Redox Potential and Energy Levels , 2011, PloS one.

[27]  Wendy A. Warr,et al.  Scientific workflow systems: Pipeline Pilot and KNIME , 2012, Journal of Computer-Aided Molecular Design.

[28]  HoltzblattKaren,et al.  Rapid Contextual Design , 2005 .

[29]  Imran Shah,et al.  Toxicology ontology perspectives. , 2012, ALTEX.

[30]  J. Noordhoek,et al.  Quinone toxicity in DT-diaphorase-efficient and -deficient colon carcinoma cell lines. , 1999, Biochemical pharmacology.

[31]  H. Mehendale,et al.  Tissue Repair: An Important Determinant of Final Outcome of Toxicant-Induced Injury , 2005, Toxicologic pathology.

[32]  G Babcock,et al.  A comparison of apoptosis and necrosis induced by hepatotoxins in HepG2 cells. , 2000, Toxicology and applied pharmacology.

[33]  M. Fielden,et al.  Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action. , 2005, Journal of biotechnology.

[34]  Thomas C. Wiegers,et al.  The Comparative Toxicogenomics Database: update 2013 , 2012, Nucleic Acids Res..

[35]  Damian Szklarczyk,et al.  The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored , 2010, Nucleic Acids Res..

[36]  M. Guenther,et al.  Histone Deacetylase Is a Direct Target of Valproic Acid, a Potent Anticonvulsant, Mood Stabilizer, and Teratogen* , 2001, The Journal of Biological Chemistry.

[37]  R. Dringen,et al.  Differential Effects of Iodoacetamide and Iodoacetate on Glycolysis and Glutathione Metabolism of Cultured Astrocytes , 2009, Front. Neuroenerg..

[38]  P. Seeman,et al.  Anti-schizophrenic drugs--membrane receptor sites of action. , 1977, Biochemical pharmacology.

[39]  Anne E. Trefethen,et al.  Toward interoperable bioscience data , 2012, Nature Genetics.

[40]  Imran Shah,et al.  A toxicology ontology roadmap. , 2012, ALTEX.

[41]  J. Bailar,et al.  Toxicity Testing in the 21st Century: A Vision and a Strategy , 2010, Journal of toxicology and environmental health. Part B, Critical reviews.

[42]  Yvonne Will,et al.  Target identification of drug induced mitochondrial toxicity using immunocapture based OXPHOS activity assays. , 2007, Toxicology in vitro : an international journal published in association with BIBRA.

[43]  T. Vanhaecke,et al.  Screening of repeated dose toxicity data present in SCC(NF)P/SCCS safety evaluations of cosmetic ingredients , 2012, Archives of Toxicology.

[44]  Egon L. Willighagen,et al.  Linked open drug data for pharmaceutical research and development , 2011, J. Cheminformatics.

[45]  Daniel L Villeneuve,et al.  Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment , 2010, Environmental toxicology and chemistry.

[46]  P. Wardman,et al.  The spontaneous and enzymatic reaction of N-acetyl-p-benzoquinonimine with glutathione: a stopped-flow kinetic study. , 1988, Archives of biochemistry and biophysics.

[47]  Jane Synnergren,et al.  Global transcriptional profiling reveals similarities and differences between human stem cell-derived cardiomyocyte clusters and heart tissue. , 2012, Physiological genomics.

[48]  T. Gant,et al.  Doxorubicin In Vivo Rapidly Alters Expression and Translation of Myocardial Electron Transport Chain Genes, Leads to ATP Loss and Caspase 3 Activation , 2010, PloS one.

[49]  Maurizio Recanatini,et al.  Safety of Non-Antiarrhythmic Drugs that Prolong the QT Interval or Induce Torsade de Pointes , 2002, Drug safety.

[50]  G. Granneman,et al.  The Hepatotoxicity of Valproic Acid and Its Metabolites in Rats. I. Toxicologic, Biochemical and Histopathologic Studies , 1984, Hepatology.

[51]  W. Koppenol.  Oxygen activation by cytochrome p450: a thermodynamic analysis. , 2007, Journal of the American Chemical Society.

[52]  R. McKay,et al.  Consensus Guidance for Banking and Supply of Human Embryonic Stem Cell Lines for Research Purposes , 2009, Stem Cell Reviews and Reports.

[53]  M Floreani,et al.  Metabolism of simple quinones in guinea pig and rat cardiac tissue. , 1995, General pharmacology.

[54]  D. Koop,et al.  Role of cytochrome P‐450 2E1 in ethanol‐, carbon tetrachloride— and iron‐dependent microsomal lipid peroxidation , 1992, Hepatology.

[55]  C. Papadimitriou,et al.  The canals of hering might represent a target of methotrexate hepatic toxicity. , 2004, American journal of clinical pathology.

[56]  Matthias Hermes,et al.  Prediction and validation of cell alignment along microvessels as order principle to restore tissue architecture in liver regeneration , 2010, Proceedings of the National Academy of Sciences.

[57]  J. Castell,et al.  Mechanism-based selection of compounds for the development of innovative in vitro approaches to hepatotoxicity studies in the LIINTOP project. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[58]  J. Hayes,et al.  The hepatotoxic metabolite of acetaminophen directly activates the Keap1‐Nrf2 cell defense system , 2008, Hepatology.

[59]  B. Copple,et al.  The Role of Hypoxia-Inducible Factor-1α in Acetaminophen Hepatotoxicity , 2011, Journal of Pharmacology and Experimental Therapeutics.

[60]  Kenji Takami,et al.  A toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in vitro screening system. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[61]  Lawrence J. Marnett,et al.  Systems Analysis of Protein Modification and Cellular Responses Induced by Electrophile Stress , 2010, Accounts of chemical research.

[62]  H. Overkleeft,et al.  Hypersensitive response to over-reactive cysteines. , 2011, Angewandte Chemie.

[63]  Shyam Biswal,et al.  Acrolein causes transcriptional induction of phase II genes by activation of Nrf2 in human lung type II epithelial (A549) cells. , 2002, Toxicology letters.

[64]  Paul Jennings,et al.  Comparative analysis of perturbed molecular pathways identified in in vitro and in vivo toxicology studies. , 2012, Toxicology in vitro : an international journal published in association with BIBRA.

[65]  L. Weber,et al.  Hepatotoxicity and Mechanism of Action of Haloalkanes: Carbon Tetrachloride as a Toxicological Model , 2003, Critical reviews in toxicology.

[66]  Barend Mons,et al.  Open PHACTS: semantic interoperability for drug discovery. , 2012, Drug discovery today.

[67]  L. Weber,et al.  Mechanism of Carbon Tetrachloride-Induced Hepatotoxicity. Hepatocellular Damage by Reactive Carbon Tetrachloride Metabolites , 2001, Zeitschrift fur Naturforschung. C, Journal of biosciences.

[68]  Kevin M Williams,et al.  Reaction of aflatoxin B(1) oxidation products with lysine. , 2002, Chemical research in toxicology.

[69]  J. Kremer.  Toward a better understanding of methotrexate. , 2004, Arthritis and rheumatism.

[70]  Pantelis Sopasakis,et al.  Collaborative development of predictive toxicology applications , 2010, J. Cheminformatics.

[71]  H. Yamada,et al.  The Japanese toxicogenomics project: application of toxicogenomics. , 2010, Molecular nutrition & food research.

[72]  Ola Spjuth,et al.  Computational toxicology using the OpenTox application programming interface and Bioclipse , 2011, BMC Research Notes.

[73]  Richard D Beger,et al.  Differential gene expression in mouse liver associated with the hepatoprotective effect of clofibrate. , 2007, Toxicology and applied pharmacology.

[74]  B. Herman,et al.  ATP depletion rather than mitochondrial depolarization mediates hepatocyte killing after metabolic inhibition. , 1994, The American journal of physiology.

[75]  Jürg Reichen,et al.  The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: A potential mechanism for hepatic adverse reactions , 2001, Clinical pharmacology and therapeutics.

[76]  Wei Tang.  Drug metabolite profiling and elucidation of drug-induced hepatotoxicity , 2007, Expert opinion on drug metabolism & toxicology.

[77]  F. Pistollato,et al.  Standardization of pluripotent stem cell cultures for toxicity testing , 2012, Expert opinion on drug metabolism & toxicology.